Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

40653 Results Found

AHE Corporate Champion Spotlight: Tork

Tork, and Essity brand, is your trusted partner in promoting wellness through efficient and sustainable solutions that enable healthcare professionals to provide evidence based hygienic care.

AHE Corporate Champion Spotlight: Rubbermaid

Rubbermaid Commercial Products (RCP) is a manufacturer of innovative, solution-based products for commercial and institutional markets worldwide.

5G investment boosts connections beyond hospital

Network expansion supports Boston Children's Hospital's mobile and virtual care expansion efforts
Public

HHS Releases Health Plan Resource Guide for Hospitals, Providers Impacted by Cyberattack

The Departments of Health and Human Services, Administration for Strategic Preparedness and Response and Centers for Medicare & Medicaid Services March 25 released a national resource guide of health plan contact information in an effort to support hospitals and providers impacted by the Change Healthcare cyberattack.

Blog: There is Nothing ‘Fair’ about the Lown Institute’s ‘Fair Share’ Report 

The latest iteration of the Lown Institute’s report on hospital community benefits suffers from the same biases, flaws and shortcomings as its previous reports, writes AHA President and CEO Rick Pollack.

Report recommends strengthening U.S. readiness for smallpox, related threats

A new report from the National Academies of Sciences, Engineering, and Medicine calls for developing better diagnostics, vaccines and treatments to enhance U.S. readiness for an outbreak or attack involving smallpox or related diseases, and systems and policies that would allow public health and health care systems to respond quickly and effectively.

Inflation rebates to reduce Medicare payment for 41 Part B drugs

This April through June under the Inflation Reduction Act, Medicare will reduce the coinsurance amount for 41 Part B prescription drugs from 20% to somewhere between 3.8% and 19.9%, depending on the drug, the Centers for Medicare & Medicaid Services announced March 26.
Member

AHA Letter to UnitedHealthcare RE: Molecular Pathology Reimbursement Policy

AHA addresses UnitedHealthcare’s implementation of its Molecular Pathology Reimbursement Policy on April 1, 2024.